Skip to content

A Clincal trial on Gowri Chinthamani Chendooram and Pachai ennai for Powthiram (Fistula-in-Ano)

A Clinical trial to determine the effectiveness of Gowri Chinthamani Chendooram (Internal) and Pachai ennai (External) in the management of Powthiram (fistula-in-ano) among patients attending Ayothidoss pandithar Hospital,National Institute of Siddha. - Anal fistula

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083184
Enrollment
20
Registered
2025-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K603- Anal fistula

Interventions

Intervention1: Gowri Chinthamani Chendooram(Internal) and Pachai ennai(External): 200 mg of Gowri Chinthamani Chendooram along with adjuvant~1.5 g(Kattukarunakilangu podi+Kadukkai podi+Sukku podi+Thip

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants having the clinical features of the following Pain and swelling in the perianal region Pus or blood discharge from perianal and anal region Skin irritation Perianal abscess Fistula tract length less than 5 cm. According to St James University Hospital Classification of Perianal Fistula,Grade I and Grade II. Participants willing to undergo Kaarathiri therapy. Participants already presenting with MRI Fistulogram or willing to undergo the MRI from recognized laboratory.

Exclusion criteria

Exclusion criteria: Infectious risk category [Tuberculosis (Genitourinary tract),Hepatitis B & C,AIDS,Syphilis] Hemophilia and bleeding disorders. Pregnancy and lactation. High anal fistula and Complicated fistula.

Design outcomes

Primary

MeasureTime frame
Outcome will be assessed by Peri-anal Disease Activity Index(PDAI) and good outcome of PDAI score becoming zero[Timepoints:Baseline and Post treatment (Day 48)]Timepoint: 18 months

Secondary

MeasureTime frame
Outcome will be assessed by Unit Cutting time, Unit cutting time=Total no f days taken for cut through/Initial length of the tract in cms=-----days/cms[Baseline and Post treatment (Day48)]Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Vetha Merlin Kumari

National Institute Of Siddha

dr.vetha@gmail.com9894782366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026